Xencor | BiotechTV

top of page

Five Questions with Xencor CEO Bassil Dahiyat

Bassil Dahiyat walks us through the latest advances in bi-specific antibody engineering and gives his take on L.A.'s biotech scene.

Bright Minds

Feb 2, 2024

Modality profile: Bi-Specifics and cytokines at #ASCO23

Xencor CEO Bassil Dahiyat walks us through the idea behind bi-specific antibodies and cytokines in cancer research.

Company News

Jun 3, 2023

Follow BiotechTV

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

Allucent Clinical Research Organization™ is on a mission to help bring new therapies to light by solving the distinct challenges of small and mid-sized biotech companies. We’re a global provider of comprehensive drug development solutions, including consulting, clinical operations, biometrics, and clinical pharmacology across a variety of therapeutic areas.

Learn more about Allucent

bottom of page

Five Questions with Xencor CEO Bassil Dahiyat

Modality profile: Bi-Specifics and cytokines at #ASCO23

Follow BiotechTV

Sponsors

Sponsor Spotlight